FAÇADE (R)-EPC

Code: 850539p-25mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Facade®-EPC has been used to produce bicelles for nuclear magnetic resonance (NMR) experiments. It may be used in crystallization of cytochrome P4...


en savoir plus

Votre prix
£198.00 25MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Facade®-EPC has been used to produce bicelles for nuclear magnetic resonance (NMR) experiments. It may be used in crystallization of cytochrome P450 2B subfamily proteins, CYP2B35 and CYP2B37.

Biochem/physiol Actions

Facade® is a mild rim forming surfactants, used in the synthesis of isotropic bicelles which prevents unfolding of soluble globular domains of large membrane proteins.

Facade® EPC/FA-7 (3α-hydroxy-7α,12α-di-(((2-(trimethylamino)ethyl)phosphoryl)ethyloxy)-cholane) having phosphocholine groups helps in preparing smaller micelles than the facial amphiphiles (FAs) with nonionic sugar groups.

Legal Information

Facade is a registered trademark of Avanti Polar Lipids, Inc.

Packaging

5 mL Amber Glass Screw Cap Vial (850539P-25mg)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 850539P
mol wt796.95 g/mol
packagingpkg of 1 × 25 mg (850539P-25mg)
shipped indry ice
SMILES string[H][C@@]12[C@]([C@](CC[C@@H](O)C3)(C)[C@]3([H])C[C@H]2OCCOP(OCC[N+](C)(C)C)([O-])=O)([H])C[C@H](OCCOP(OCC[N+](C)(C)C)([O-])=O)[C@@]4(C)[C@@]1([H])CC[C@@H]4[C@H](C)CCC
storage temp.−20°C
Cas Number1429405-99-1
Ce produit répond aux critères suivants: